| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8684489 | European Journal of Paediatric Neurology | 2016 | 8 Pages |
Abstract
IGF-1 may rescue function in Rett syndrome and ASD caused by changes of the SCHANK3 gene. There are recently pilot studies of the treatment of Rett syndrome and of SCHANK3 gene deficiency syndromes. The FDA has granted Orphan drug designations for Fragile X syndrome, SCHANK3 gene deficiency syndrome and Rett syndrome.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Raili Riikonen,